Assays for macromolecular analytes

Abstract

A method of determining a macromolecular analyte in a sample suspected of containing the macromolecular analyte is disclosed. The sample and a conjugate reagent comprising a small molecule and a binding partner for the macromolecular analyte are combined in a medium. The conjugate reagent and a labeled binding partner for the small molecule are combined. The conjugate reagent or the medium is examined for an amount of labeled binding partner for the small molecule that is bound to the small molecule, which is related to the amount of the macromolecular analyte in the sample.

What is claimed is: 
     
         1 . A method of determining a macromolecular analyte in a sample suspected of containing the macromolecular analyte, the method comprising:
 (a) combining in a medium the sample and a conjugate reagent comprising a small molecule and a binding partner for the macromolecular analyte,   (b) combining the conjugate reagent and a labeled binding partner for the small molecule, and   (c) examining the conjugate reagent or the medium for an amount of labeled binding partner for the small molecule that is bound to the small molecule and relating the amount thereof to the amount of the macromolecular analyte in the sample.   
     
     
         2 . The method according to  claim 1 , wherein the macromolecular analyte is selected from the group consisting of antibodies, enzymes, hormones, polynucleotides, and carbohydrates. 
     
     
         3 . The method according to  claim 1  wherein the conjugate reagent further comprises a support to which the small molecule and the binding partner for the macromolecular analyte are bound. 
     
     
         4 . The method according to  claim 3 , wherein the support is a non-magnetic particle, a magnetic particle, a plate, or a tube. 
     
     
         5 . The method according to  claim 1 , wherein the small molecule is selected from the group consisting of biotin, desthiobiotin, dinitrophenol, digoxin, digoxigenin, rhodamine, and fluorescein. 
     
     
         6 . The method according to  claim 1 , wherein the label of the labeled binding partner is selected from the group consisting of enzymes, fluorescers, chemiluminescers, bioluminescers, electroluminescers, sensitizers, and radioactive materials. 
     
     
         7 . The method according to  claim 3 , wherein the support comprises a label wherein the label is interactive with the label of the labeled binding partner. 
     
     
         8 . The method according to  claim 1 , wherein the sample is a body excretion, body aspirant, body excisant or body extractant. 
     
     
         9 . The method according to  claim 1 , wherein the small molecule is bound to the binding partner for the macromolecular analyte. 
     
     
         10 . A method of determining an antibody analyte in a sample suspected of containing the antibody analyte, the method comprising:
 (a) providing in combination in a medium:
 (i) the sample, 
 (ii) a support having bound thereto a small molecule and an antigen that binds to the antibody analyte, and 
 (iii) a labeled binding partner for the small molecule, 
   (b) incubating the medium under conditions for binding of the labeled binding partner to the small molecule, and   (c) examining the support or the medium for an amount of labeled binding partner bound to the small molecule and relating the amount thereof to the amount of the antibody analyte in the sample.   
     
     
         11 . The method according to  claim 10 , wherein the support is a non-magnetic particle, a magnetic particle, a plate, or a tube. 
     
     
         12 . The method according to  claim 10 , wherein the small molecule is selected from the group consisting of biotin, desthiobiotin, dinitrophenol, digoxin, digoxigenin, rhodamine, and fluorescein. 
     
     
         13 . The method according to  claim 10 , wherein the label of the labeled binding partner is selected from the group consisting of enzymes, fluorescers, chemiluminescers, bioluminescers, electroluminescers, sensitizers, and radioactive materials. 
     
     
         14 . The method according to  claim 10 , wherein the support comprises a label wherein the label is interactive with the label of the labeled binding partner. 
     
     
         15 . The method according to  claim 1 , wherein the sample is a body excretion, body aspirant, body excisant or body extractant. 
     
     
         16 . The method according to  claim 1 , wherein the method is a homogeneous assay method. 
     
     
         17 . A method of determining an antibody analyte in a sample suspected of containing the antibody analyte, the method comprising:
 (a) providing in combination in a medium:
 (i) the sample, 
 (ii) a particle having bound thereto a small molecule and an antigen that binds to the antibody analyte, and 
 (iii) a labeled binding partner for the small molecule, 
   (b) incubating the medium under conditions for binding of the labeled binding partner to the small molecule, and   (c) examining the support or the medium for an amount of labeled binding partner bound to the small molecule and relating the amount thereof to the amount of the antibody analyte in the sample.   
     
     
         18 . The method according to  claim 17 , wherein the labeled binding partner is labeled with a particle comprising a sensitizer label and the particle having bound thereto a small molecule comprises a chemiluminescent label. 
     
     
         19 . The method according to  claim 17  wherein the particle having bound thereto a small molecule is a magnetic particle. 
     
     
         20 . The method according to  claim 17  wherein the small molecule is bound to the antigen, which is bound to the particle.